20:12 EDT Cathie Wood’s ARK Investment bought 47.6K shares of Verve Therapeutics today
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VERV:
- Verve Establishes Global Collaboration with Lilly to Advance Verve’s In Vivo Gene Editing Program Targeting Lp(a) for the Treatment of Atherosclerotic Cardiovascular Disease
- Verve Therapeutics announces research collaboration with Eli Lilly
- Verve Therapeutics to Participate in the 2023 Jefferies Healthcare Conference
- Verve Therapeutics to Participate in the Stifel 2023 Tailoring Genes: Virtual Genetic Medicines Day
- Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results